Table 1.
Trait | Variant | Chr | Position | Locus | N | EA/NEA | EAF | Adjusted for age, sex |
Adjusted for age, sex, BMI |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta | SE | P-value | Phet | Beta | SE | P-value | Phet | ||||||||
TG | rs10886863 | 10 | 122,929,493 | WDR11-FGFR2 | 45,245 | C/T | 0.64 | 0.041 | 0.007 | 2.71 × 10−8 | 0.275 | 0.041 | 0.006 | 2.73 × 10−10 | 0.175 |
HDL-C | rs10743940 | 12 | 7,651,138 | CD163-APOBEC1 | 34,243 | A/T | 0.30 | 0.050 | 0.009 | 7.00 × 10−9 | 0.105 | 0.050 | 0.008 | 2.30 × 10−9 | 0.163 |
HDL-C | rs10504476 | 8 | 71,267,629 | NCOA2 | 42,731 | G/A | 0.60 | 0.040 | 0.007 | 2.11 × 10−7 | 0.993 | 0.042 | 0.007 | 1.62 × 10−8 | 0.812 |
HDL-C | rs10144765 | 14 | 52,559,930 | NID2-PTDGR | 54,176 | G/C | 0.27 | 0.031 | 0.007 | 1.63 × 10−6 | 0.626 | 0.035 | 0.007 | 4.16 × 10−8 | 0.380 |
East Asian meta-analysis results from Phases 1 and 2 (without and with adjustment for BMI). Genome-wide significant association is defined as P < 5 × 10−8. Physical positions based on hg19. Effect alleles are associated with higher triglyceride and HDL-C trait values. Beta estimates reflect per allele effects of variants on inverse normal transformed traits. rs10743940 at CD163-APOBEC1 attained genome-wide significance at Phase 2 (N up to 34,421). The other three loci attained genome-wide significance from combined analysis of Phase 1 discovery, in silico, and de novo stages (N up to 61,607 for HDL-C, and N up to 45,839 for TG).
Chr, chromosome; EA, effect allele; NEA, non-effect allele; EAF, effect allele frequency; SE, standard error; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol.